<DOC>
	<DOC>NCT00533468</DOC>
	<brief_summary>The study's hypothesis is LMX4 cream, a topical anesthetic cream, will reduce the pain of infants undergoing Lumbar Puncture (spinal tap).</brief_summary>
	<brief_title>"Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age."</brief_title>
	<detailed_description>Pain of infants will be measured using the Neonatal Facial Coding System by videotaping the infant's face while they undergo the procedure. A comparison between the group that received active drug and the group that received placebo will allow a measurement of the difference, if any, of the pain experienced during the procedure of the infants.</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Full term (&gt;=37 weeks gestation) Age 060 Days Undergoing Lumbar Puncture Unstable Premature (&lt;37 weeks gestation) Allergy to study medicine Parent refusal of consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>60 Days</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>pain</keyword>
	<keyword>lumbar puncture</keyword>
	<keyword>neonates</keyword>
	<keyword>infants</keyword>
	<keyword>emergency department</keyword>
	<keyword>topical anesthesia</keyword>
	<keyword>LMX4</keyword>
</DOC>